20 June 2013
Keywords: osi, tarceva, debut, japan, dec, usa-based, pharmaceuticals
Article | 24 December 2007
USA-based OSI Pharmaceuticals says that its drug Tarceva (erlotinib) has been listed on Japan's National Health Insurance drug reimbursement
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 December 2007
19 June 2013
© 2013 thepharmaletter.com